Potential clinical implications of an incidental renomedullary interstitial cell tumor in renal allograft biopsy.

Autor: Narasimhan B; Nephrologist, Sathyam Kidney Care Centre, Coimbatore, India., Gaspar BL; Director, NextGenPath Diagnostics, 34/29 Nallasiriyar Nagar, Thottipalayam, Coimbatore, India.
Jazyk: angličtina
Zdroj: Medical journal, Armed Forces India [Med J Armed Forces India] 2023 Jul-Aug; Vol. 79 (4), pp. 474-477. Date of Electronic Publication: 2021 Apr 12.
DOI: 10.1016/j.mjafi.2021.02.005
Abstrakt: Renomedullary interstitial cell tumors (RMICTs) are often incidentally detected lesions at autopsy or resection of the kidney for other reasons. The RMICTs have not been reported in renal allograft biopsy. Overall, given the clinical implications of the differential diagnosis considered, such as morphologically similar neoplasms, interstitial fibrosis and tubular atrophy (IFTA), amyloidosis, and oxalosis, it is prudent to exclude these by an appropriate workup. Once excluded, the patients can be reassured. However, regular follow-up is recommended due to the propensity of RMICT to increase in size with age.
Competing Interests: The authors have none to declare.
(© 2021 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.)
Databáze: MEDLINE
Externí odkaz: